Showing results (361-370 of 10,059) with videos related to
Sort By:
Pageof 1,006
Current Pharmaceutical Design|September 9, 2022
Advanced Research in Cellular Pharmacokinetics and its Cutting-edge TechnologiesLingjuan Lv, Yuyang You, Yeju Liu, et al.Current Pharmaceutical Design|September 29, 2022
Epigallocatechin Gallate Protects Diabetes Mellitus Rats Complicated with Cardiomyopathy through TGF-β1/JNK Signaling PathwayLiuming Gui, Fengxian Wang, Xiangka Hu, et al.Current Pharmaceutical Design|February 19, 2021
A Comprehensive Review on the Ethnobotany, Phytochemistry, Pharmacology, and Toxicology of Mentha aquatic L (water mint) as a Wild Shallow VegetableFarzaneh Asadollah-Pour, Assie Jokar, Ebrahim Nasiri, et al.Current Pharmaceutical Design|September 26, 2022
Significant Role of Long Non-coding RNAs in Parkinson's DiseaseChen Na, Chen Wen-Wen, Wang Li, et al.Current Pharmaceutical Design|September 26, 2022
Acarbose Potentially Binds to the Type I Peptide Deformylase Catalytic Site and Inhibits Bacterial Growth: An In Silico and In Vitro StudyAtul Kumar Singh, Kumari Sunita Prajapati, Shashank KumarCurrent Pharmaceutical Design|June 3, 2011
Neuregulin1 as novel therapy for heart failureXinhua Yan, James P MorganCurrent Pharmaceutical Design|June 3, 2011
Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failureToshinori Aoyagi, Takashi MatsuiCurrent Pharmaceutical Design|June 3, 2011
Vitamin D therapy in cardiac hypertrophy and heart failureJ Ruth Wu-WongCurrent Pharmaceutical Design|May 10, 2011
New cell therapy using bone marrow-derived stem cells/endothelial progenitor cells to accelerate neovascularization in healing of experimental ulcerative colitisXiaoming Deng, Sandor Szabo, Longchuan Chen, et al.Current Pharmaceutical Design|May 10, 2011
Gastric ulcerogenic and healing impairment actions of alendronate, a nitrogen-containing bisphosphonate - prophylactic effects of rebamipideKoji Takeuchi, Shinichi Kato, Kikuko AmagasePageof 1,006